Literature DB >> 15818659

Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.

Swati Bhattacharyya1, Asish K Ghosh, Jaspreet Pannu, Yasuji Mori, Shinsuke Takagawa, Guofen Chen, Maria Trojanowska, Anita C Gilliam, John Varga.   

Abstract

OBJECTIVE: Transforming growth factor beta (TGFbeta) induces profibrotic responses in normal fibroblasts, and plays a fundamental role in the pathogenesis of fibrosis in scleroderma (systemic sclerosis [SSc]). The intensity of cellular responses elicited by cytokines is modulated by transcriptional coactivators such as the histone acetylase p300. The objective of these studies was to delineate the physiologic role of p300 in Smad-dependent profibrotic responses elicited by TGFbeta.
METHODS: Ectopic p300 was transiently expressed in normal dermal fibroblasts. Cellular p300 levels were suppressed using p300-specific ribozymes. The regulation of gene expression was examined by transient transfection assays, Northern blotting, and immunoblot analysis. The expression of p300 in normal and scleroderma fibroblasts was evaluated by confocal microscopy and immunoblotting, and p300 levels in skin from mice with experimental scleroderma were assessed by immunohistochemistry.
RESULTS: In normal fibroblasts, TGFbeta induced an increase in the levels of p300. Forced expression of ectopic p300 in these cells dramatically enhanced the magnitude of TGFbeta responses, whereas selective depletion of p300 using ribozyme resulted in abrogation of TGFbeta-induced collagen synthesis and promoter activity. Furthermore, TGFbeta lost its ability to induce Smad-dependent transcription in p300-depleted fibroblasts. These responses could be fully rescued with ectopic p300. Abrogation of Smad-mediated TGFbeta signaling was not due to alterations in the levels or the ligand-dependent phosphorylation or intracellular trafficking of endogenous Smads. Immunohistochemical analysis demonstrated substantially increased p300 expression in lesional skin from mice with chronic graft-versus-host disease, an animal model of scleroderma. Furthermore, levels of p300 were 2-3-fold higher in cultured fibroblasts derived from SSc patients than in fibroblasts from matched normal controls.
CONCLUSION: These results establish, for the first time, that the coactivator histone acetylase p300, itself a target of TGFbeta regulation, is an essential component of the cellular TGFbeta signal transduction pathways mediating stimulation of collagen synthesis in fibroblasts. Since the cellular abundance of p300 appears to govern the intensity of profibrotic responses elicited by TGFbeta, elevated p300 expression in lesional tissue may contribute to the progression of skin fibrosis in scleroderma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15818659     DOI: 10.1002/art.20996

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  30 in total

Review 1.  Early growth response transcription factors: key mediators of fibrosis and novel targets for anti-fibrotic therapy.

Authors:  Swati Bhattacharyya; Minghua Wu; Feng Fang; Warren Tourtellotte; Carol Feghali-Bostwick; John Varga
Journal:  Matrix Biol       Date:  2011-04-13       Impact factor: 11.583

Review 2.  Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities.

Authors:  Swati Bhattacharyya; Jun Wei; John Varga
Journal:  Nat Rev Rheumatol       Date:  2011-10-25       Impact factor: 20.543

Review 3.  Recent advances in the treatment of systemic sclerosis.

Authors:  Vasiliki Kalliopi K Bournia; Panayiotis G Vlachoyiannopoulos; Carlo Selmi; Haralampos M Moutsopoulos; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

4.  Inhibition of β-Catenin Signaling in the Skin Rescues Cutaneous Adipogenesis in Systemic Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial of C-82.

Authors:  Robert Lafyatis; Julio C Mantero; Jessica Gordon; Nina Kishore; Mary Carns; Howard Dittrich; Robert Spiera; Robert W Simms; John Varga
Journal:  J Invest Dermatol       Date:  2017-08-12       Impact factor: 8.551

Review 5.  From genetics to epigenetics: new insights into keloid scarring.

Authors:  Yongjing He; Zhenjun Deng; Mansour Alghamdi; Lechun Lu; Mark W Fear; Li He
Journal:  Cell Prolif       Date:  2017-01-05       Impact factor: 6.831

Review 6.  Molecular pathogenesis of skin fibrosis: insight from animal models.

Authors:  Gideon P Smith; Edwin S L Chan
Journal:  Curr Rheumatol Rep       Date:  2010-02       Impact factor: 4.592

7.  Curcumin prevents and reverses murine cardiac hypertrophy.

Authors:  Hong-Liang Li; Chen Liu; Geoffrey de Couto; Maral Ouzounian; Mei Sun; Ai-Bing Wang; Yue Huang; Cheng-Wei He; Yu Shi; Xin Chen; Mai P Nghiem; Youan Liu; Manyin Chen; Fayez Dawood; Masahiro Fukuoka; Yuichiro Maekawa; Liyong Zhang; Andrew Leask; Asish K Ghosh; Lorrie A Kirshenbaum; Peter P Liu
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

8.  Mitochondrial reactive oxygen species regulate transforming growth factor-β signaling.

Authors:  Manu Jain; Stephanie Rivera; Elena A Monclus; Lauren Synenki; Aaron Zirk; James Eisenbart; Carol Feghali-Bostwick; Gokhan M Mutlu; G R Scott Budinger; Navdeep S Chandel
Journal:  J Biol Chem       Date:  2012-11-30       Impact factor: 5.157

9.  Constitutive Smad signaling and Smad-dependent collagen gene expression in mouse embryonic fibroblasts lacking peroxisome proliferator-activated receptor-gamma.

Authors:  Asish K Ghosh; Jun Wei; Minghua Wu; John Varga
Journal:  Biochem Biophys Res Commun       Date:  2008-07-15       Impact factor: 3.575

10.  Peroxisome proliferator-activated receptor-gamma abrogates Smad-dependent collagen stimulation by targeting the p300 transcriptional coactivator.

Authors:  Asish K Ghosh; Swati Bhattacharyya; Jun Wei; Suyeon Kim; Yaacov Barak; Yasuji Mori; John Varga
Journal:  FASEB J       Date:  2009-04-24       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.